Latest cancer therapies Stories
PRINCETON, N.J., Feb. 19 /PRNewswire/ -- Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, has announced a $55 million Series C financing.
PRINCETON, N.J., Feb.
Rapid Identification and Optimization of Novel Drug Candidates using CLIMB(TM) DUBLIN, Calif., Jan. 26 /PRNewswire-FirstCall/ -- SuperGen, Inc.
DUBLIN, Calif., Dec. 8 /PRNewswire-FirstCall/ -- SuperGen Inc.
TSX: BMR TORONTO, Dec.
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.
TORONTO, Nov. 3 /PRNewswire-FirstCall/ -- Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, announced today that Dr. Alan M.
DUBLIN, Calif., Oct. 23 /PRNewswire-FirstCall/ -- SuperGen, Inc.
WALTHAM, Mass., Oct.
- A young chicken: also used as a pet name for children.